Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Published:2001-06 Issue:6 Volume:7 Page:343-351
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Boeckh Michael,Bowden Raleigh A.,Storer Barry,Chao Nelson J.,Spielberger Ricardo,Tierney D. Kathryn,Gallez-Hawkins Ghislaine,Cunningham Terri,Blume Karl G.,Levitt Daniel,Zaia John A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Cytomegalovirus infection after BMT;Boeckh,1998

2. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation;Einsele;Blood,1995

3. Cytomegalovirus pp65 antigenemia guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;Boeckh;Blood,1996

4. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia;Hansen;N Engl J Med,1998

5. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation;Goodrich;N Engl J Med,1991

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer;Immunity;2023-11

2. Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents;Trends in Microbiology;2023-08

3. Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease;Trends in Microbiology;2023-05

4. Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections;Biomedicines;2022-08-02

5. A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice;PLOS Pathogens;2022-06-23